Cloudbreak Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-41.83	-99.13	-129.42	-66.84
Depreciation & Amortization	0.95	1.23	0.83	0.33
Loss (Gain) From Sale of Assets	-	-	-	0
Loss (Gain) From Sale of Investments	-	-	-	-0.06
Stock-Based Compensation	11.27	11.27	13.57	1.35
Other Operating Activities	4.26	60.86	91.62	42.99
Change in Accounts Payable	0.15	0.15	1.08	2.48
Change in Other Net Operating Assets	-0.9	-0.9	-0.18	-0.3
Operating Cash Flow	-26.11	-26.52	-22.51	-20.05
Capital Expenditures	-0.17	-0.16	-0.56	-0.78
Investment in Securities	-	7.5	55.69	-30.64
Other Investing Activities	0.26	2.03	2.22	1.6
Investing Cash Flow	0.08	9.37	57.36	-29.82
Short-Term Debt Issued	-	14	284.93	-
Total Debt Issued	14	14	284.93	-
Short-Term Debt Repaid	-	-14	-284.93	-0.09
Long-Term Debt Repaid	-	-0.33	-0.3	-0.19
Total Debt Repaid	-14.35	-14.33	-285.23	-0.28
Net Debt Issued (Repaid)	-0.35	-0.33	-0.3	-0.28
Other Financing Activities	-0.09	-0.13	-0.45	-14.06
Financing Cash Flow	-0.44	-0.46	2.05	-14.34
Foreign Exchange Rate Adjustments	0.56	-0.19	-0.16	-0.48
Net Cash Flow	-25.91	-17.79	36.74	-64.69
Free Cash Flow	-26.28	-26.68	-23.06	-20.83
Free Cash Flow Margin	-256.59%	-261.18%	-2620.68%	-4422.08%
Free Cash Flow Per Share	-0.06	-0.06	-0.05	-0.04
Cash Interest Paid	0.03	0.03	0.28	0.03
Cash Income Tax Paid	1.18	1.04	-0.08	0.22
Levered Free Cash Flow	-	-12.04	-122.15	-
Unlevered Free Cash Flow	-	-12.03	-121.98	-
Change in Working Capital	-0.76	-0.76	0.89	2.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.